Product Images Ogivri
View Photos of Packaging, Labels & Appearance
Product Label Images
The following 10 images provide visual information about the product associated with Ogivri NDC 83257-003 by Biocon Biologics Inc., such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.
Figure 6 shows the duration of disease-free survival in patients with adjuvant treatment of breast cancer in Study 4. The graph displays different treatment combinations, including AC->T (doxorubicin + cyclophosphamide followed by docetaxel and trastuzumab), AC->TH (doxorubicin + cyclophosphamide followed by docetaxel, platinum salt, and trastuzumab), and TCH (docetaxel, platinum salt, and trastuzumab). The x-axis represents the number of years of disease-free survival, while the y-axis represents the number of patients. The Kaplan-Meier estimates are used to calculate the survival rates.*
* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.